Get the Stockscreener App
110.56
0.66%
-0.74
After Hours:
111.00
0.44
+0.40%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
T Rowe Price Group Inc stock is traded at $110.56, with a volume of 1.03M.
It is down -0.66% in the last 24 hours and down -4.75% over the past month.
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
See More
Previous Close:
$111.30
Open:
$110.93
24h Volume:
1.03M
Relative Volume:
0.49
Market Cap:
$23.58B
Revenue:
$7.41B
Net Income/Loss:
$2.14B
P/E Ratio:
11.85
EPS:
9.33
Net Cash Flow:
$2.70B
1W Performance:
-3.03%
1M Performance:
-4.75%
6M Performance:
+17.92%
1Y Performance:
+1.38%
1-Day Range:
$109.76
$111.47
1-Week Range:
$109.73
$115.01
52-Week Range:
$85.22
$122.00
T Rowe Price Group Inc Stock (TROW) Company Profile
Name
T Rowe Price Group Inc
Sector
Industry
Phone
(410) 345-2000
Address
HARBOR POINT, BALTIMORE, MD
Compare TROW vs BLK, BX, BN, BAM, APO
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TROW
T Rowe Price Group Inc
|
110.56 | 23.77B | 7.41B | 2.14B | 2.70B | 9.33 |
BLK
Blackrock Inc
|
1,173.73 | 179.79B | 27.61B | 7.13B | 3.76B | 40.76 |
BX
Blackstone Inc
|
143.93 | 109.90B | 16.59B | 6.83B | 869.79M | 4.4576 |
BN
Brookfield Corp
|
43.85 | 109.54B | 77.61B | 4.06B | -8.36B | 0.497 |
BAM
Brookfield Asset Management Ltd
|
54.31 | 87.05B | 5.07B | 2.48B | 2.37B | 1.5532 |
APO
Apollo Global Management Inc
|
140.76 | 81.86B | 31.69B | 2.94B | 8.43B | 1.5206 |
T Rowe Price Group Inc Stock (TROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Aug-27-24 | Initiated | Barclays | Underweight |
| Apr-11-24 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Apr-08-24 | Upgrade | TD Cowen | Sell → Hold |
| Jan-08-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-04-24 | Initiated | TD Cowen | Underperform |
| Oct-31-23 | Upgrade | Citigroup | Sell → Neutral |
| May-19-23 | Initiated | Citigroup | Sell |
| Dec-15-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Initiated | Credit Suisse | Underperform |
| Jul-11-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jun-13-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Apr-11-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-12-22 | Reiterated | Citigroup | Sell |
| Jan-04-22 | Downgrade | Goldman | Neutral → Sell |
| Dec-17-21 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-16-21 | Resumed | BofA Securities | Underperform |
| Oct-22-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-14-21 | Downgrade | Citigroup | Neutral → Sell |
| Mar-30-21 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-05-21 | Upgrade | Goldman | Sell → Neutral |
| Nov-19-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-24-20 | Downgrade | Goldman | Neutral → Sell |
| Jan-02-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-08-19 | Initiated | BMO Capital Markets | Market Perform |
| Mar-08-19 | Reiterated | BofA/Merrill | Buy |
| Jan-31-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-19 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-18 | Reiterated | BofA/Merrill | Buy |
| Oct-26-18 | Reiterated | Barclays | Underweight |
| Sep-07-18 | Downgrade | Deutsche Bank | Buy → Hold |
| May-16-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-09-18 | Upgrade | UBS | Sell → Neutral |
| Jan-08-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-27-17 | Reiterated | Barclays | Underweight |
| Oct-05-17 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-28-17 | Upgrade | Goldman | Neutral → Buy |
| Sep-08-17 | Initiated | Barclays | Underweight |
| May-24-17 | Downgrade | UBS | Buy → Sell |
| Apr-26-17 | Downgrade | Argus | Buy → Hold |
| Mar-17-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
View All
T Rowe Price Group Inc Stock (TROW) Latest News
T. Rowe Price (TROW) Q2 2026 Earnings Call Transcript - AOL.com
T. Rowe Price Group (NASDAQ:TROW) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
D.A. Davidson & CO. Has $6.46 Million Stake in T. Rowe Price Group, Inc. $TROW - MarketBeat
T. Rowe Price (TROW) Reworks Leadership To Speed AI Push And Back Crypto - Yahoo Finance
TROW|T Rowe Price Group Inc|Price:110.560|Chg%:-0.740 - TradingKey
T. Rowe Price Associates (THG) discloses 5.2% Hanover Insurance ownership stake - Stock Titan
T. Rowe Price (MLTX holder) discloses 5.3% MoonLake Immunotherapeutics position - Stock Titan
T. Rowe Price Investment Management (PRAA) discloses 7.9% PRA Group ownership - Stock Titan
T. Rowe Price (VICR) discloses 7.0% beneficial stake in Vicor common stock - Stock Titan
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
T. Rowe Price Investment Management (PCTY) discloses 5.8% Paylocity ownership in 13G/A - Stock Titan
T. Rowe Price (SVV) discloses 7.39M-share position in Savers Value Village - Stock Titan
T. Rowe Price Investment Management (AIZ) reports 4.9% Assurant stake in 13G/A - Stock Titan
T. Rowe Price Investment Management (MTSI) discloses 2.85M MACOM shares in 13G/A - Stock Titan
T. Rowe Price (UNIT) discloses 5.0% Uniti Group ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (GHM) discloses 5.2% Graham Corp ownership - stocktitan.net
T. Rowe Price Investment Management (USCB) discloses 8.6% ownership of USCB Financial - Stock Titan
T. Rowe Price Investment Management (GLNG) discloses 6.2% Golar LNG common stock holding - Stock Titan
T. Rowe Price Investment Management (TFX) discloses 7.2% ownership in Teleflex - stocktitan.net
T. Rowe Price Investment Management (MIAX) discloses 5.3% holding in Miami International - Stock Titan
T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs - Stock Titan
T. Rowe Price Investment Management (MPTI) discloses 5.9% holding in M-TRON Industries - stocktitan.net
T. Rowe Price updates 6.5% Safehold Inc. (SAFE) ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (BELFA) discloses 4.4% Bel Fuse Inc-CL B holding - Stock Titan
T. Rowe Price Investment Management (NI) discloses 6.2% beneficial stake in NiSource - stocktitan.net
T. Rowe Price Investment Management (DCBG) discloses 7.2% Dime Community stake - Stock Titan
T. Rowe Price Investment Management (PTC) discloses 13.1M-share position in PTC Inc. - Stock Titan
T. Rowe Price Investment Management (EQBK) discloses 11.4% Equity Bancshares ownership - Stock Titan
Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake - Stock Titan
T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan
T. Rowe Price Associates (HXL) discloses 5.86M-share position in Hexcel - Stock Titan
T. Rowe Price (WOLF) discloses 6.1M Wolfspeed shares held for clients - Stock Titan
T. Rowe Price (MQ) discloses 11.6% Marqeta stake; Mid-Cap Value Fund holds 5.1% - Stock Titan
Skyward Specialty (SKWD): T. Rowe Price Associates reports 6% ownership stake - Stock Titan
T. Rowe Price Associates (NTRA) discloses 9.0M-share Natera stake in updated 13G - Stock Titan
T. Rowe Price Associates (SMA) reports 5.27M-share, 9.5% stake in SmartStop - Stock Titan
T. Rowe Price Associates (VRDN) discloses 5.2% Viridian Therapeutics ownership in 13G - Stock Titan
T. Rowe Price (CCC) discloses 7.5% beneficial stake in CCC Intelligent Solutions - stocktitan.net
T. Rowe Price Associates (MRX) discloses 6.8% Marex Group holding in 13G - Stock Titan
T. Rowe Price Associates (SARO) discloses 13.6% holding in StandardAero Inc. - Stock Titan
T. Rowe Price stakes 5.6% in Keysight Technologies (KEYS) common stock - Stock Titan
T. Rowe Price reports 9.8M Old Dominion Freight Line (ODFL) shares - Stock Titan
T. Rowe Price Associates (AAP) reports 14% stake in Advance Auto Parts common stock - Stock Titan
T. Rowe Price (PEB) discloses 8.58M-share Pebblebrook Hotel Trust stake in 13G/A - Stock Titan
T. Rowe Price Associates (IBP) discloses 4.3% holding in Installed Building Products - stocktitan.net
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
T. Rowe Price Associates (VRRM) reports 241,697 Verra Mobility shares in 13G/A - Stock Titan
T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - stocktitan.net
Cullinan Therapeutics (CGEM): T. Rowe Price reports 6.2% ownership stake - Stock Titan
T. Rowe Price Associates (KNF) reports 5.1M Knife River Corp shares, a 9% stake - Stock Titan
Shoals Technologies (SHLS): T. Rowe Price reports 12.9% ownership stake - Stock Titan
T Rowe Price Group Inc Stock (TROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):